Published in Vaccine Weekly, February 25th, 2004
"Endogenous retrovirus (ERV) products are recognized by T lymphocytes in mice and humans. As these antigens are preferentially expressed by neoplastic tissues, they might represent an ideal target for active immunization by genetic vaccination. However, i.m. inoculation of plasmid DNA encoding mouse gp70 or p15E, two products of the env gene of an endogenous murine leukemia virus, elicited a weak antigen-specific T lymphocyte response and resulted in partial protection from challenge with mouse tumors possessing these...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly